Your email has been successfully added to our mailing list.

×
0 0 -0.00520833333333334 0 -0.00520833333333334 -0.00520833333333334 0.00463541666666662 -0.00520833333333334
Stock impact report

New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperpl...

Nymox Pharmaceutical Corporation (NYMX) 
US:NASDAQ Investor Relations: nymox.com/default.action?itemid=3
Company Research Source: Canadian Busine
New Peer Review Article Entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia” Published in Therapeutic Advances in Urology, The Canadian Business Journal makers HASBROUCK HEIGHTS, N.J., Jan. 15, 2019 (GLOBE NEWSWIRE) — Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reports today that a new peer review article has been published in Therapeutic Advances in Urology. The new publication reviews current progress in the development of Fexapotide Triflutate, Nymox’s first-in-class new molecular approach to managing the symptoms of benign prostatic hyperplasia (BPH).The new article is entitled “Efficacy and safety of fexapotide triflutate in outpatient medical treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia” and is authored by Neal Shore, MD, FACS (Carolina Urologic Research Center, Myrtle Beach, SC); Ronald Tutrone, MD, FACS (Chesa Show less Read more
Impact Snapshot
Event Time:
NYMX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for NYMX alerts
Opt-in for
NYMX alerts

from News Quantified
Opt-in for
NYMX alerts

from News Quantified